骨质疏松症药物治疗研究进展

被引：6

作者：

高凯 ^{[1
,2
]}

李云霞 ^{[1
,2
]}

陈世益 ^{[1
,2
]}

机构：

[1] 复旦大学运动医学中心

[2] 复旦大学附属华山医院运动医学与关节镜外科

来源：

上海医药 | 2012年 / 33卷 / 15期

关键词：

骨质疏松症; 药物治疗; 进展;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

随着老龄化社会的来临,骨质疏松症的发病率逐渐升高,成为影响绝经后妇女和中、老年人健康的严重公共卫生问题,造成巨大的经济和社会负担。治疗骨质疏松症的药物的作用机制主要包括两个方面,即抑制骨吸收和促进骨形成。本文综述骨质疏松症药物治疗的研究进展。

引用

页码：16 / 19

页数：4

共 10 条

[1]

新型骨质疏松症治疗药物德诺苏单抗及其临床地位和市场趋势 [J].

马培奇 .

上海医药, 2011, 32 (03) :150-151

[2]

Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized Controlled Trial [J].

Grey, Andrew ;

Bolland, Mark ;

Wong, Sumwai ;

Horne, Anne ;

Gamble, Greg ;

Reid, Ian R. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01) :286-292

[3]

Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture [J].

Boonen, Steven ;

Orwoll, Eric ;

Magaziner, Jay ;

Colon-Emeric, Cathleen S. ;

Adachi, Jonathan D. ;

Bucci-Rechtweg, Christina ;

Haentjens, Patrick ;

Kaufman, Jean-Marc ;

Rizzoli, Rene ;

Vanderschueren, Dirk ;

Claessens, Frank ;

Sermon, An ;

Witvrouw, Richard ;

Milisen, Koen ;

Su, Guoqin ;

Lyles, Kenneth W. .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (11) :2084-2090

[4]

Denosumab for the Reduction of Bone Loss in Postmenopausal Osteoporosis: A Review [J].

Bridgeman, Mary Barna ;

Pathak, Rolee .

CLINICAL THERAPEUTICS, 2011, 33 (11) :1547-1559

[5]

Osteoporosis: now and the future [J].

Rachner, Tilman D. ;

Khosla, Sundeep ;

Hofbauer, Lorenz C. .

LANCET, 2011, 377 (9773) :1276-1287

[6]

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years [J].

Reginster, J. Y. ;

Bruyere, O. ;

Sawicki, A. ;

Roces-Varela, A. ;

Fardellone, P. ;

Roberts, A. ;

Devogelaer, J. P. .

BONE, 2009, 45 (06) :1059-1064

[7]

Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis [J].

Kendler, D. L. ;

Ringe, J. D. ;

Ste-Marie, L. -G. ;

Vrijens, B. ;

Taylor, E. B. ;

Delmas, P. D. .

OSTEOPOROSIS INTERNATIONAL, 2009, 20 (11) :1895-1902

[8]

Osteoporosis [J].

Sambrook, Philip ;

Cooper, Cyrus .

LANCET, 2006, 367 (9527) :2010-2018

[9]

Epidemiology and outcomes of osteoporotic fractures [J].

Cummings, SR ;

Melton, LJ .

LANCET, 2002, 359 (9319) :1761-1767

[10]

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

← 1 →